Theodore M Brasky

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort
    Theodore M Brasky
    The Fred Hutchinson Cancer Research Center, Cancer Prevention Unit, Seattle, WA 98109 1024, USA
    Cancer Causes Control 23:431-44. 2012
  2. ncbi Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort
    Theodore M Brasky
    Cancer Prevention Unit, The Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4 B402, Seattle, WA 98109 1024, USA
    Cancer Causes Control 22:1333-42. 2011
  3. ncbi Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort
    Theodore M Brasky
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Nutr Cancer 63:573-82. 2011
  4. ncbi Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial
    Theodore M Brasky
    Department of Epidemiology, University of Washington, Seattle, Washington, USA
    Am J Epidemiol 173:1429-39. 2011
  5. ncbi Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype
    Theodore M Brasky
    Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA
    Cancer Causes Control 22:965-75. 2011
  6. ncbi Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort
    Theodore M Brasky
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4 B402, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 19:3185-8. 2010
  7. ncbi Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study
    Theodore M Brasky
    Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA
    Breast Cancer Res Treat 126:157-65. 2011
  8. ncbi Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort
    Theodore M Brasky
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 B402, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 19:1696-708. 2010
  9. ncbi Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study
    Theodore M Brasky
    Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, USA
    Cancer Causes Control 21:1503-12. 2010
  10. ncbi Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study
    Roland B Walter
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 20:2298-308. 2011

Detail Information

Publications14

  1. ncbi Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort
    Theodore M Brasky
    The Fred Hutchinson Cancer Research Center, Cancer Prevention Unit, Seattle, WA 98109 1024, USA
    Cancer Causes Control 23:431-44. 2012
    ..A recent meta-analysis of randomized trials of aspirin reported a reduction in cancer mortality; however, few studies have investigated whether aspirin or other NSAIDs reduce overall cancer risk...
  2. ncbi Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort
    Theodore M Brasky
    Cancer Prevention Unit, The Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4 B402, Seattle, WA 98109 1024, USA
    Cancer Causes Control 22:1333-42. 2011
    ..After an additional year of follow-up, we further examined the association including frequency/duration of use, interaction with factors associated with inflammation, and lung cancer histology...
  3. ncbi Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort
    Theodore M Brasky
    Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Nutr Cancer 63:573-82. 2011
    ..Grapeseed may be a potential chemopreventive agent; however, as current evidence is limited, it should not yet be promoted for prevention of prostate cancer...
  4. ncbi Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial
    Theodore M Brasky
    Department of Epidemiology, University of Washington, Seattle, Washington, USA
    Am J Epidemiol 173:1429-39. 2011
    ..48, 95% CI: 0.27, 0.84). The study findings are contrary to those expected from the pro- and antiinflammatory effects of these fatty acids and suggest a greater complexity of effects of these nutrients with regard to prostate cancer risk...
  5. ncbi Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype
    Theodore M Brasky
    Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA
    Cancer Causes Control 22:965-75. 2011
    ..28, 95% CI: 1.04-1.57), as well as luminal A or B breast cancers. These findings support the hypothesis of heterogeneous etiologies of breast cancer subtypes and that aspirin and ibuprofen vary in their effects...
  6. ncbi Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort
    Theodore M Brasky
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4 B402, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 19:3185-8. 2010
    ..Several epidemiologic studies have reported inverse associations between nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk, although many studies are limited by assessment of short-term use only...
  7. ncbi Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study
    Theodore M Brasky
    Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA
    Breast Cancer Res Treat 126:157-65. 2011
    ..Better understanding of the role of COX-2 genetic variation and interaction with NSAID use in breast carcinogenesis has potential to inform prevention strategies...
  8. ncbi Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort
    Theodore M Brasky
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 B402, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 19:1696-708. 2010
    ..However, there have been no prospective studies of the association between the long-term use of these supplements and breast cancer risk...
  9. ncbi Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study
    Theodore M Brasky
    Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, USA
    Cancer Causes Control 21:1503-12. 2010
    ..Results of studies of non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer have been inconsistent. Timing of exposure and analysis of individual NSAIDs should be considered...
  10. ncbi Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study
    Roland B Walter
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 20:2298-308. 2011
    ..Increasing evidence suggests that nutrients from fruits and vegetables have chemoprotective effects on various cancers including hematologic malignancies, but the effects of nutritional supplements are poorly examined...
  11. ncbi Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis
    Yanli Li
    Department of Social and Preventive Medicine, State University of New York at Buffalo, 265 Farber Hall, Buffalo, NY 14214, USA
    Cancer Epidemiol Biomarkers Prev 21:239-42. 2012
    ..While there is accumulating evidence that use of nonsteroidal anti-inflammatory drugs (NSAID) decreases breast cancer risk, little is known about the impact of NSAIDs on survival after breast cancer diagnosis...
  12. ncbi Tonsillectomy and breast cancer risk in the Western New York Diet Study
    Theodore M Brasky
    Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14214, USA
    Cancer Causes Control 20:369-74. 2009
    ..Exposures during early life may affect risk of breast cancer. History of tonsillectomy has recently been associated with risk of several cancers, including cancer of the breast...
  13. ncbi Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study
    Roland B Walter
    Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109 1024, USA
    J Clin Oncol 29:2424-31. 2011
    ..Herein, we used a large prospective cohort study to examine these associations...
  14. ncbi Cancer risk associated with long-term use of acetaminophen in the prospective VITamins and lifestyle (VITAL) study
    Roland B Walter
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 20:2637-41. 2011
    ....